Download PDF
Ultrasound Int Open 2016; 02(02): E63-E67
DOI: 10.1055/s-0042-106393
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Objective Assessment of Cervical Stiffness after Administration of Misoprostol for Intrauterine Contraceptive Insertion

S. Badir
1   Swiss Federal Institute of Technology Zurich, Institute of Mechanical Systems, Zurich, Switzerland
,
E. Mazza
1   Swiss Federal Institute of Technology Zurich, Institute of Mechanical Systems, Zurich, Switzerland
2   EMPA, Swiss Federal Laboratories for Materials Testing and Research, Dübendorf, Switzerland
,
M. Bajka
3   University Hospital Zurich, OB/GYN, Zurich, Switzerland
› Author Affiliations
Further Information

Publication History

received 27 October 2015

accepted 22 March 2016

Publication Date:
03 May 2016 (online)

   Permissions and Reprints

Abstract

Purpose:

The goal of this study was to objectively quantify cervical stiffness in misoprostol users prior to IUC insertion and at follow-up consultation to evaluate the feasibility of assessing cervical stiffness and to study the influence of misoprostol on cervical softening.

Materials and Methods:

This was a cross-sectional study that evaluated 40 women who wished to use the LNG IUS. These women were evaluated immediately before LNG IUS insertion and 6 weeks later at follow-up consultation. Participants received 200 μg of misoprostol combined with 75 mg of diclofenac in a single tablet orally (Arthrotec forte 75/200®, Pfizer, USA) 6–12 h prior to insertion in “off label” use. On both occasions, cervical stiffness was determined using a novel medical device based on the aspiration technique. The Wilcoxon rank-sum and the Wilcoxon signed-rank test were applied to compare cervical stiffness assessments at insertion of the IUD and at follow-up.

Results:

For the first time, cervical stiffness was quantitatively assessed in misoprostol users prior to IUD insertion, proving that the aspiration technique enables detection of pharmacologically induced cervical changes, and also that misoprostol has a detectable softening effect on cervical tissue.

Conclusion:

The clinical value of the detected cervical softening after misoprostol administration remains unclear. Aspiration measurements could be helpful in searching for the ideal candidate, the appropriate route, dosage and interval of misoprostol intake prior to IUC insertion.

Key words

cervical stiffness - cervical softening - cervical priming - misoprostol - aspiration technique
 

  • References

  • 1 Winner B, Peipert J, Qiuhong Z et al. Effectiveness of Long-Acting Reversible Contraception. N Engl J Med 2012; 366: 1998-2007
    CrossrefPubMedGoogle Scholar
  • 2 Hubacher D, Reyes V, Lillo S et al. Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen. Am J Obstet Gynecol 2006; 195: 1272-1277
    CrossrefPubMedGoogle Scholar
  • 3 Allen R, Bartz D, Da G et al. Interventions for pain with intrauterine device insertion. Cochrane Database Syst Rev 2009;
    PubMedGoogle Scholar
  • 4 Heikinheimo O, Inki P, Kunz M et al. Double-blind, randomized, placebo-controlled study on the effect of misoprostol on ease of consecutive insertion of the levonorgestrel releasing intrauterine system. Contraception 2010; 81: 481-486
    CrossrefPubMedGoogle Scholar
  • 5 Marions L, Lövkvist L, Taube A et al. Use of the levonorgestrel releasing-intrauterine system in nulliparous women – a noninterventional study in Sweden. Eur J Contracept Reprod Health Care 2011; 16: 126-134
    CrossrefPubMedGoogle Scholar
  • 6 Gonzalez J, Franzke C, Yang F et al. Complement activation triggers metalloproteinases release inducing cervical remodelling and preterm birth in mice. Am J Pathol 2011; 179: 838-848
    CrossrefPubMedGoogle Scholar
  • 7 Norman M, Ekman G, Malmström A. Prostaglandin E2-induced ripening of the human cervix involves changes in proteoglycan metabolism. Obstet Gynecol 1993; 82: 1013-1020
    PubMedGoogle Scholar
  • 8 Akins M, Luby-Phelps K, Bank R et al. Cervical softening during pregnancy: regulated changes in collagen crosslinking and composition of matricellular proteins in the mouse. Biol Reprod 2011; 84: 1053-1062
    CrossrefPubMedGoogle Scholar
  • 9 Myers KM, Feltovich H, Mazza E et al. The mechanical role of the cervix in pregnancy. J Biomech 2015; 48: 1511-1523
    CrossrefPubMedGoogle Scholar
  • 10 Lathrop E, Haddad L, McWhorter CP et al. Self-administration of misoprostol prior to intrauterine device insertion among nulliparous women: a randomized controlled trial. Contraception 2013; 88: 725-729
    CrossrefPubMedGoogle Scholar
  • 11 Choksuchat C, Cheewadhanaraks S, Getpook C et al. Misoprostol for cervical ripening in non-pregnant women: a randomized double-blind controlled trial of oral versus vaginal regimens. Hum Reprod 2006; 21: 2167-2170
    CrossrefPubMedGoogle Scholar
  • 12 Farmer M, Webb A. Intrauterine device insertion-related complications: can they be predicted?. J Fam Plann Reprod Health Care 2003; 29: 227-231
    CrossrefPubMedGoogle Scholar
  • 13 Kaislasuo J, Suhonen S, Gissler M et al. Uterine perforation caused by intrauterine devices: clinical course and treatment. Hum Reprod 2012; 27: 2658-2663
    CrossrefPubMedGoogle Scholar
  • 14 Sääv I, Aronsson a, Marions L et al. Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial. Hum Reprod 2007; 22: 2647-2652
    CrossrefPubMedGoogle Scholar
  • 15 Scavuzzi A, Souza ASR, Costa R et al. Misoprostol prior to inserting an intrauterine device in nulligravidas: a randomized clinical trial. Hum Reprod 2013; 28: 2118-2125
    CrossrefPubMedGoogle Scholar
  • 16 Lotke PS, Tiwari A, Nuño VL. Inserting intrauterine devices in nulliparous women: is misoprostol beneficial?. A registered clinical trial 2013; 1: 62-68
    PubMedGoogle Scholar
  • 17 Espey E, Singh RH, Leeman L et al. Misoprostol for intrauterine device insertion in nulliparous women: a randomized controlled trial. Am J Obstet Gynecol 2014; 210: 1-5
    CrossrefPubMedGoogle Scholar
  • 18 Dijkhuizen K, Dekkers OM, Holleboom CG et al. Vaginal misoprostol prior to insertion of an intrauterine device: an RCT. Hum Reprod 2011; 26: 323-329
    CrossrefPubMedGoogle Scholar
  • 19 Gemzell-Danielsson K, Mansour D, Fiala C et al. Management of pain associated with the insertion of intrauterine contraceptives. Hum Reprod Update 2013; 19: 419-427
    CrossrefPubMedGoogle Scholar
  • 20 Li YT, Kuo TC, Kuan LC et al. Cervical softening with vaginal misoprostol before intrauterine device insertion. Int J Gynaecol Obstet 2005; 89: 67-68
    CrossrefPubMedGoogle Scholar
  • 21 Li Y-T, Wen-Ling L, Peng-Hui W. Difficult intrauterine device insertion. Hum Reprod 2011; 26: 2192-2193
    CrossrefPubMedGoogle Scholar
  • 22 Bahamondes L, Mansour D, Fiala C et al. Practical advice for avoidance of pain associated with insertion of intrauterine contraceptives. J Fam Plann Reprod Health Care 2014;40: 54–60. [182] Crane J. prime the cervix for hysteroscopy? Obstet Gynecol Manag 2008; 20: 27-29
    PubMedGoogle Scholar
  • 23 Ward K, Jacobson JC, Turok DK et al. A survey of provider experience with misoprostol to facilitate intrauterine device insertion in nulliparous women. Contraception 2011; 84: 594-599
    CrossrefPubMedGoogle Scholar
  • 24 Badir S, Bajka M, Mazza E. A novel procedure for the mechanical characterization of the uterine cervix during pregnancy. J Mech Behav Biomed Mater 2013; 27: 143-153
    CrossrefPubMedGoogle Scholar
  • 25 Badir S, Mazza E, Zimmermann R et al. Cervical softening occurs early in pregnancy: characterization of cervical stiffness in 100 healthy women using the aspiration technique. Prenat Diagn 2013; 33: 737-741
    CrossrefPubMedGoogle Scholar